Despite all the hype, augmented intelligence (AKA artificial intelligence or AI) is and has been a real thing in programming. The power does continue to grow—just like all technology. Two areas ripe for improvement through the use of AI are education and healthcare. This news relates to healthcare.
Emory University is embarking on a new initiative that will unite the power of machine learning and big data to transform the ways in which health care systems prevent, diagnose, treat and cure diseases on a global scale.
Launching this month under the umbrella of Emory’s AI.Humanity initiative, the Emory Empathetic AI for Health Institute will utilize artificial intelligence (AI) and computing power to discern patterns in vast amounts of data and make predictions that improve patient health outcomes in diseases such as lung, prostate and breast cancer, heart disease, diabetes and more. While AI is already being deployed to improve diagnoses and treatment for numerous health conditions, the resounding impact AI can have on health care is just beginning.
As Georgia’s first institute of its kind, Emory AI.Health will foster the development of accessible, cost-effective and equitable AI tools by developing an ecosystem of multidisciplinary experts from Emory, the Atlanta VA Medical Center, the Georgia Institute of Technology and others, and seeking public-private partnerships to propel new research forward. It will then serve as an engine to deploy those tools to the patient’s bedside, initially within Emory Healthcare and ultimately across the globe.
“AI will transform society and at Emory, we want to use these powerful technologies to save and improve lives,” says Emory President Gregory L. Fenves. “We see the power AI has to facilitate healing while improving equitable access to health care. Dr. Madabhushi is a trailblazer in health-focused AI and the ideal person to lead the Empathetic AI for Health Institute.”
Emory AI.Health will be led by Anant Madabhushi, PhD, a Robert W. Woodruff professor in the Wallace H. Coulter Department of Biomedical Engineering at Emory and Georgia Institute of Technology, a member of the Cancer Immunology research program at Winship Cancer Institute and a research career scientist with the Atlanta VA Medical Center.
